Piper Sandler Keeps Their Buy Rating on Amgen (AMGN)
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...
UBS Remains a Hold on Equinor ASA (0M2Z)
In a report released today, Henri Patricot from UBS maintained a Hold rating on Equinor ASA (0M2Z – Research Report), with a price target of ...